<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(1)</volume><submitter>Fernandez Lahore G</submitter><funding>Knut och Alice Wallenbergs Stiftelse</funding><pubmed_abstract>Complex autoimmune diseases are sexually dimorphic. An interplay between predisposing genetics and sex-related factors probably controls the sex discrepancy in the immune response, but the underlying mechanisms are unclear. Here we positionally identify a polymorphic estrogen receptor binding site that regulates Cd2 expression, leading to female-specific differences in T cell-dependent mouse models of autoimmunity. Female mice with reduced Cd2 expression have impaired autoreactive T cell responses. T cells lacking Cd2 costimulation upregulate inhibitory Lag-3. These findings help explain sexual dimorphism in human autoimmunity, as we find that CD2 polymorphisms are associated with rheumatoid arthritis and 17-β-estradiol-regulation of CD2 is conserved in human T cells. Hormonal regulation of CD2 might have implications for CD2-targeted therapy, as anti-Cd2 treatment more potently affects T cells in female mice. These results demonstrate the relevance of sex-genotype interactions, providing strong evidence for CD2 as a sex-sensitive predisposing factor in autoimmunity.</pubmed_abstract><journal>Nature communications</journal><pagination>5565</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8458462</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Polymorphic estrogen receptor binding site causes Cd2-dependent sex bias in the susceptibility to autoimmune diseases.</pubmed_title><pmcid>PMC8458462</pmcid><pubmed_authors>Zubarev RA</pubmed_authors><pubmed_authors>Fernandez Lahore G</pubmed_authors><pubmed_authors>Johannesson M</pubmed_authors><pubmed_authors>He Y</pubmed_authors><pubmed_authors>Sabatier P</pubmed_authors><pubmed_authors>Lonnblom E</pubmed_authors><pubmed_authors>Forster M</pubmed_authors><pubmed_authors>Aoun M</pubmed_authors><pubmed_authors>Nandakumar KS</pubmed_authors><pubmed_authors>Holmdahl R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Polymorphic estrogen receptor binding site causes Cd2-dependent sex bias in the susceptibility to autoimmune diseases.</name><description>Complex autoimmune diseases are sexually dimorphic. An interplay between predisposing genetics and sex-related factors probably controls the sex discrepancy in the immune response, but the underlying mechanisms are unclear. Here we positionally identify a polymorphic estrogen receptor binding site that regulates Cd2 expression, leading to female-specific differences in T cell-dependent mouse models of autoimmunity. Female mice with reduced Cd2 expression have impaired autoreactive T cell responses. T cells lacking Cd2 costimulation upregulate inhibitory Lag-3. These findings help explain sexual dimorphism in human autoimmunity, as we find that CD2 polymorphisms are associated with rheumatoid arthritis and 17-β-estradiol-regulation of CD2 is conserved in human T cells. Hormonal regulation of CD2 might have implications for CD2-targeted therapy, as anti-Cd2 treatment more potently affects T cells in female mice. These results demonstrate the relevance of sex-genotype interactions, providing strong evidence for CD2 as a sex-sensitive predisposing factor in autoimmunity.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2024-10-19T07:20:54.75Z</modification><creation>2022-02-11T11:55:07.558Z</creation></dates><accession>S-EPMC8458462</accession><cross_references><pubmed>34552089</pubmed><doi>10.1038/s41467-021-25828-5</doi></cross_references></HashMap>